CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Famotidine

法莫替丁 杂质对照品Famotidine Impurities

EP43 个杂质条目43 impurity entries

本页汇总 法莫替丁 的 43 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 43 impurity reference standards of Famotidine with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 法莫替丁(Famotidine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and validation of chromatographic methods for simultaneous determination of ibuprofen and famotidine in presence of related substances in pharmaceutical formulations
    Acta chimica Slovenica · 2015 · Elzanfaly ES et al.  ·  PMID 25830959  ·  DOI
  2. 杂质研究Impurity studiesMultivariate Validated Models for Simultaneous Determination of Ibuprofen and Famotidine in the Presence of Related Substances
    Journal of AOAC International · 2018 · Elzanfaly ES et al.  ·  PMID 28874228  ·  DOI
  3. 杂质研究Impurity studiesStability-Indicating HPLC Method for Determination of Ibuprofen and Famotidine Degradation Products
    Journal of chromatographic science · 2024 · Atilgan N et al.  ·  PMID 38727201  ·  DOI
  4. 分析方法Analytical MethodsRP-UPLC method development and validation for the simultaneous estimation of ibuprofen and famotidine in pharmaceutical dosage form
    Pharmaceutical methods · 2012 · Reddy YR et al.  ·  PMID 23781479  ·  DOI
  5. 分析方法Analytical MethodsReversed-phase determination of famotidine, potential degradates, and preservatives in pharmaceutical formulations by high-performance liquid chromatography using silica as a stationary phase
    Journal of chromatography · 1986 · Biffar SE, Mazzo DJ  ·  PMID 3771687  ·  DOI

法莫替丁 —— 原料药与杂质对照品Famotidine — drug substance & impurities

共 44 个条目(含原料药本体)44 items incl. the drug substance
Famotidine structure
EP原料药 APIAPI
法莫替丁Famotidine
Famotidine
CAS No.76824-35-6
Chemical FormulaC8H15N7O2S3
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 1(Famotidine EP Impurity A) structure
EPA
法莫替丁杂质1(法莫替丁EP杂质A)Famotidine Impurity 1(Famotidine EP Impurity A)
Famotidine Impurity 1(Famotidine EP Impurity A)
CAS No.76833-47-1
Chemical FormulaC8H15ClN6S2
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 1 Dihydrochloride (Famotidine EP Impurity A Dihydrochloride) structure
EPA
法莫替丁杂质1 双盐酸盐(法莫替丁EP杂质A 双盐酸盐)Famotidine Impurity 1 Dihydrochloride (Famotidine EP Impurity A Dihydrochloride)
Famotidine Impurity 1 Dihydrochloride (Famotidine EP Impurity A Dihydrochloride)
CAS No.88061-72-7
Chemical FormulaC8H14N6S2·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 2 Dimaleate (Famotidine EP Impurity B Dimaleate) structure
EPB
法莫替丁杂质2 双马来酸盐 (法莫替丁EP杂质B 双马来酸盐)Famotidine Impurity 2 Dimaleate (Famotidine EP Impurity B Dimaleate)
Famotidine Impurity 2 Dimaleate (Famotidine EP Impurity B Dimaleate)
CAS No.109467-08-5
Chemical FormulaC16H23N11O2S5·2(C4H4O4)
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 2 (Famotidine EP Impurity B) structure
EPB
法莫替丁杂质2 (法莫替丁EP杂质B)Famotidine Impurity 2 (Famotidine EP Impurity B)
Famotidine Impurity 2 (Famotidine EP Impurity B)
CAS No.89268-62-2
Chemical FormulaC16H23N11O2S5
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 3 Monomer (Famotidine EP Impurity C) structure
EPC
法莫替丁杂质3 单体 (法莫替丁EP杂质C)Famotidine Impurity 3 Monomer (Famotidine EP Impurity C)
Famotidine Impurity 3 Monomer (Famotidine EP Impurity C)
CAS No.106433-44-7
Chemical FormulaC8H14N6O3S3
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 3 (Famotidine EP Impurity C Hydrochloride) structure
EPC
法莫替丁杂质3 (法莫替丁EP杂质C 盐酸盐)Famotidine Impurity 3 (Famotidine EP Impurity C Hydrochloride)
Famotidine Impurity 3 (Famotidine EP Impurity C Hydrochloride)
CAS No.76824-17-4
Chemical FormulaC8H14N6O3S3·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 4 (Famotidine EP Impurity D) structure
EPD
法莫替丁杂质4 (法莫替丁EP杂质D)Famotidine Impurity 4 (Famotidine EP Impurity D)
Famotidine Impurity 4 (Famotidine EP Impurity D)
CAS No.76824-16-3
Chemical FormulaC8H13N5OS2
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 5 (Famotidine EP Impurity E) structure
EPE
法莫替丁杂质5 (法莫替丁EP杂质E)Famotidine Impurity 5 (Famotidine EP Impurity E)
Famotidine Impurity 5 (Famotidine EP Impurity E)
CAS No.129083-44-9
Chemical FormulaC10H14N8S4
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 6(Famotidine EP Impurity F) structure
EPF
法莫替丁杂质6(法莫替丁EP杂质F)Famotidine Impurity 6(Famotidine EP Impurity F)
Famotidine Impurity 6(Famotidine EP Impurity F)
CAS No.107880-74-0
Chemical FormulaC8H12N4O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 7 (Famotidine EP Impurity G) structure
EPG
法莫替丁杂质7 (法莫替丁EP杂质G)Famotidine Impurity 7 (Famotidine EP Impurity G)
Famotidine Impurity 7 (Famotidine EP Impurity G)
CAS No.76823-97-7
Chemical FormulaC9H13N7S2
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 13 Monomer (Famotidine EP Impurity H) structure
EPH
法莫替丁杂质13 单体 (法莫替丁EP杂质H)Famotidine Impurity 13 Monomer (Famotidine EP Impurity H)
Famotidine Impurity 13 Monomer (Famotidine EP Impurity H)
CAS No.106649-96-1
Chemical FormulaC6H10N6S2
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 13 (Famotidine EP Impurity H Dihydrochloride) structure
EPH
法莫替丁杂质13 (法莫替丁EP杂质H 双盐酸盐)Famotidine Impurity 13 (Famotidine EP Impurity H Dihydrochloride)
Famotidine Impurity 13 (Famotidine EP Impurity H Dihydrochloride)
CAS No.88046-01-9
Chemical FormulaC6H10N6S2·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 8(Famotidine EP Impurity I) structure
EPI
法莫替丁杂质8(法莫替丁EP杂质I)Famotidine Impurity 8(Famotidine EP Impurity I)
Famotidine Impurity 8(Famotidine EP Impurity I)
CAS No.1020719-36-1
Chemical FormulaC8H14N6O4S3
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 9(Famotidine EP Impurity J) structure
EPJ
法莫替丁杂质9(法莫替丁EP杂质J)Famotidine Impurity 9(Famotidine EP Impurity J)
Famotidine Impurity 9(Famotidine EP Impurity J)
CAS No.76824-14-1
Chemical FormulaC9H14N4O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 4-d4 (Famotidine EP Impurity D-d4) structure
EPD-D4
法莫替丁杂质4-d4 (法莫替丁EP杂质D-d4)Famotidine Impurity 4-d4 (Famotidine EP Impurity D-d4)
Famotidine Impurity 4-d4 (Famotidine EP Impurity D-d4)
CAS No.1327321-45-8
Chemical FormulaC8H9D4N5OS2
Purity>95%询价On request
Famotidine EP Impurity F-d4 structure
EPF-D4
法莫替丁EP杂质F-d4Famotidine EP Impurity F-d4
Famotidine EP Impurity F-d4
CAS No.1324230-60-5
Chemical FormulaC713CH8D4N4O2S2
Purity>95%询价On request
Famotidine Impurity 10 structure
10
法莫替丁杂质10Famotidine Impurity 10
Famotidine Impurity 10
CAS No.90237-03-9
Chemical FormulaC8H15N7O3S3
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 11 structure
11
法莫替丁杂质11Famotidine Impurity 11
Famotidine Impurity 11
CAS No.76823-94-4
Chemical FormulaC9H15N5OS2
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 12 structure
12
法莫替丁杂质12Famotidine Impurity 12
Famotidine Impurity 12
CAS No.76823-93-3
Chemical FormulaC8H11N5S2
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 14 Hydrochloride structure
14
法莫替丁杂质14 盐酸盐Famotidine Impurity 14 Hydrochloride
Famotidine Impurity 14 Hydrochloride
CAS No.69014-12-6
Chemical FormulaC5H7ClN4S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 14 structure
14
法莫替丁杂质14Famotidine Impurity 14
Famotidine Impurity 14
CAS No.81152-53-6
Chemical FormulaC5H7ClN4S
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 15 structure
15
法莫替丁杂质15Famotidine Impurity 15
Famotidine Impurity 15
CAS No.7803-58-9
Chemical FormulaH4N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 16 structure
16
法莫替丁杂质16Famotidine Impurity 16
Famotidine Impurity 16
CAS No.128648-99-7
Chemical FormulaC3H8N2O
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 17 structure
17
法莫替丁杂质17Famotidine Impurity 17
Famotidine Impurity 17
CAS No.2651-43-6
Chemical FormulaC3H7NO2
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 18 structure
18
法莫替丁杂质18Famotidine Impurity 18
Famotidine Impurity 18
CAS No.503-66-2
Chemical FormulaC3H6O3
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 22 structure
22
法莫替丁杂质22Famotidine Impurity 22
Famotidine Impurity 22
CAS No.95853-51-3
Chemical FormulaC5H8N4S2
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 25 (Famotidine Sulfone) structure
25
法莫替丁杂质25(法莫替丁砜)Famotidine Impurity 25 (Famotidine Sulfone)
Famotidine Impurity 25 (Famotidine Sulfone)
CAS No.158844-17-8
Chemical FormulaC8H15N7O4S3
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 26 structure
26
法莫替丁杂质26Famotidine Impurity 26
Famotidine Impurity 26
CAS No.95853-46-6
Chemical FormulaC3H7N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 27 structure
27
法莫替丁杂质27Famotidine Impurity 27
Famotidine Impurity 27
CAS No.154480-53-2
Chemical FormulaC9H20ClN2O4P
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 30 structure
30
法莫替丁杂质30Famotidine Impurity 30
Famotidine Impurity 30
CAS No.86794-42-5
Chemical FormulaC5H8N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 31 structure
31
法莫替丁杂质31Famotidine Impurity 31
Famotidine Impurity 31
CAS No.106649-95-0
Chemical FormulaC3H8ClN3O2S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 32 structure
32
法莫替丁杂质32Famotidine Impurity 32
Famotidine Impurity 32
CAS No.5875-24-1
Chemical FormulaC3H6ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 34 structure
34
法莫替丁杂质34Famotidine Impurity 34
Famotidine Impurity 34
CAS No.29671-92-9
Chemical FormulaCH3ClN2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 42 structure
42
法莫替丁杂质42Famotidine Impurity 42
Famotidine Impurity 42
CAS No.7120-01-6
Chemical FormulaC5H8N4S
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 43 Monomer structure
43
法莫替丁杂质43 单体Famotidine Impurity 43 Monomer
Famotidine Impurity 43 Monomer
CAS No.1644079-90-2
Chemical FormulaC3H8ClN3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 46 structure
46
法莫替丁杂质46Famotidine Impurity 46
Famotidine Impurity 46
CAS No.1378820-83-7
Chemical FormulaC5H7ClN4S
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 46 Hydrochloride structure
46
法莫替丁杂质46 盐酸盐Famotidine Impurity 46 Hydrochloride
Famotidine Impurity 46 Hydrochloride
CAS No.1644079-28-6
Chemical FormulaC5H7ClN4S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 48 structure
48
法莫替丁杂质48Famotidine Impurity 48
Famotidine Impurity 48
CAS No.31407-74-6
Chemical FormulaC3H8N2O·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 50 structure
50
法莫替丁杂质50Famotidine Impurity 50
Famotidine Impurity 50
CAS No.77219-57-9
Chemical FormulaC9H17N7O2S3
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 53 structure
53
法莫替丁杂质53Famotidine Impurity 53
Famotidine Impurity 53
CAS No.154754-59-3
Chemical FormulaC9H15N7O2S3
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 54 structure
54
法莫替丁杂质54Famotidine Impurity 54
Famotidine Impurity 54
CAS No.95907-34-9
Chemical FormulaC5H9ClN4OS
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 55 structure
55
法莫替丁杂质55Famotidine Impurity 55
Famotidine Impurity 55
CAS No.105683-44-1
Chemical FormulaC4H11N5O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Famotidine Impurity 62 structure
62
法莫替丁杂质62Famotidine Impurity 62
Famotidine Impurity 62
CAS No.2169078-41-3
Chemical FormulaC3H7N3O2S
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

法莫替丁 —— 研究文献与合成路线Famotidine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 法莫替丁 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Famotidine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability indicating method for famotidine in pharmaceuticals using porous graphitic carbon column
    Helali N, Monser L · Journal of separation science · 2008 · 被引 11cited 11
  2. Photochemical Mechanism of Riboflavin-Induced Degradation of Famotidine and a Suggested Pharmaceutical Strategy for Improving Photostability
    Uchida A, Onoue S, Ohtake H, et al. · Journal of pharmaceutical sciences · 2016 · 被引 5cited 5
  3. Stability-Indicating HPLC Method for Determination of Ibuprofen and Famotidine Degradation Products
    Atilgan N, Tabansiz G, Turkes E, et al. · Journal of chromatographic science · 2024
  4. Pharmaceutical application of LC-MS. 1--Characterization of a famotidine degradate in a package screening study by LC-APCI MS
    Qin XZ, Ip DP, Chang KH, et al. · Journal of pharmaceutical and biomedical analysis · 1994 · 被引 20cited 20
  5. Feasibility of rapidly assessing reactive impurities mediated excipient incompatibility using a new method: A case study of famotidine-PEG system
    Saraf I, Modhave D, Kushwah V, et al. · Journal of pharmaceutical and biomedical analysis · 2020 · 被引 7cited 7
  6. Capillary zone electrophoresis method for the determination of famotidine and related impurities in pharmaceuticals
    Helali N, Tran NT, Monser L, et al. · Talanta · 2008 · 被引 10cited 10

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR STABILIZING FAMOTIDINE
    GARCIA ARMANTA MARIA ELENA, ALVAREZ OCHOA VICTOR GUILLERMO, SANTOS MURILLO JOSEFINA · 公开号 EP2085079EP2085079 · 2009
  2. PROCESS FOR STABILIZING FAMOTIDINE
    MURILLO JOSEFINA SANTOS, ARMENTA MARIA ELENA GARCIA, OCHOA VICTOR GUILLERMO ALVAREZ · 公开号 MXPA06010972MXPA06010972 · 2009
  3. Famotidine high density type gastric retention osmotic pump controlled release preparation and preparation method thereof
    WEISAN PAN, JIN GUAN, LIYING ZHOU · 公开号 CN101380313CN101380313 · 2009
  4. Famotidine polymorphic forms and their preparation process
    Ballester-Rodes Montserrat, Palomo-Nicolau Francisco Eugenio, Palomo-Coll Antonio Luis · 公开号 EP0297019EP0297019 · 1988
  5. Morphologically homogenous forms of famotidine and processes for their preparation
    Bod Peter, Harsanyi Kalman, Hegedus Bela, Bogsch Erik, et al. · 公开号 EP0256747EP0256747 · 1988

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

法莫替丁 杂质谱研究要点Famotidine — impurity profiling notes

下面这些是拿到 法莫替丁 的 44 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 44 impurity entries for Famotidine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances